Clinical investigation of medicinal products used in the treatment of osteoarthritis - Scientific guideline

This document provides guidance on the clinical evaluation of medicinal products in the treatment of osteoarthritis.

Keywords: Osteoarthritis, symptom modifying drugs, structure modifying drugs, non-steroidal anti-inflammatory drugs (NSAIDs), clinical development

Current effective version

Guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis

Adopted Reference Number: CPMP/EWP/784/97 Rev. 1 Legal effective date: 01/08/2010

Document history

Guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis

Adopted Reference Number: CPMP/EWP/784/97 Rev. 1 Legal effective date: 01/08/2010

Overview of comments received on draft guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis

Adopted Reference Number: EMA/818496/2009

Draft guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis

Draft: consultation closed Reference Number: CPMP/EWP/784/97 Rev. 1

Concept paper on the need for revision of points to consider on clinical investigation of medicinal products for the treatment of osteoarthritis (CPMP/EWP/784/97)

Reference Number: EMEA/CHMP/EWP/141412/2008